OBJECTIVES: The objective of this study was to assess the cost of diabetes and cardiovascular disease management and to estimate and compare the prescription costs for the management of patients with the different complications based on real world data

METHODS: This was an observational, monocentric, retrospective study conducted during 2 years (2019 and 2020) from patients medical records. The study was set up in EPH Birtraria, Algiers, Algeria and assessed the direct and indirect costs generated by the management of diabetes and cardiovascular diseases. The collection of data was classified in two groups based on therapeutic area (cardiology and diabetology).

RESULTS: The economic data collection was available for 2800 patients at the internal medicine department, repartition per therapeutic area is 44% for cardiology and 56% for diabetology. This study allowed to define the care pathway and the medical resources consumed in the management of patients. Total direct cost was 1.4millions euros (600K € for cardiology and 818 K € for diabetology) and 242K euros for indirect costs (140 K € for cardiology and 101 K € for diabetology). Medical resources used by patients were : 56 K € for nursing, 356 K € for disease management costs (hospitalizations costs, radiology and analysis costs), 770 K € were pharmacy costs, and 686 k € were spent for physician costs.

CONCLUSIONS: In our knowledge, this is the first study to assess the healthcare utilization and economic burden of diabetes and cardiovascular disease. The direct and indirect costs generated by these diseases in Algeria represent a real economic and societal burden for patients and health authorities